Difference between revisions of "Cohn and Wolfe Ltd"
John Ashmore (talk | contribs) |
|||
| Line 1: | Line 1: | ||
{{Template:Foodspin badge}} | {{Template:Foodspin badge}} | ||
| + | {{Template:Pharma_Portal_badge}} | ||
| + | '''Cohn & Wolfe''' - a subsidiary of [[WPP]] - describes itself as a "strategic marketing public relations firm dedicated to creating, building and protecting the world's most prolific brands."<ref>[http://www.cohnwolfe.com/Content.aspx?NodeId=6 Cohn & Wolfe website]</ref> It has offices all over the world including UK, US, throughout Europe, Latin America, Middle East, and the Asia Pacific region. | ||
| − | ''' | + | The firm claims to be an agency for the 'new communications landscape'. It is a global public relations agency with 50 offices in major markets around the world. They 'offer a powerful combination of breakthrough, brand-building creativity and pioneering digital and social media strategies.' <ref>Cohn & Wolfe. [http://www.cohnwolfe.com/en/about-us Cohn & Wolfe About Us]. Accessed on 24 October 2009.</ref> |
| + | |||
| + | The firm's 10 industry practices are Consumer Branding, Corporate, Digital, Energy, Entertainment, Healthcare, Public Affairs, Sports Marketing, Sustainability and Technology. | ||
It offers clients 'strategic partnerships' with other WPP companies, including [[Quinn Gillespie]], a lobbying firm. | It offers clients 'strategic partnerships' with other WPP companies, including [[Quinn Gillespie]], a lobbying firm. | ||
Cohn and Wolfe has also teamed up with lobbying firm [[Open Road]] in the UK. <ref>APPC register, 12 2006 - 03 2007</ref> | Cohn and Wolfe has also teamed up with lobbying firm [[Open Road]] in the UK. <ref>APPC register, 12 2006 - 03 2007</ref> | ||
| + | |||
| + | ==Healthcare== | ||
| + | |||
| + | '''Cohne & Wolfe''' recognise that Healthcare PR is changing and encourage clients to search for new models in communicating effectively to healthcare professionals, consumers and payors. The agency in turn creates 'bold creative strategies' with a focus on providing consumers with more information to take more active roles in their healthcare. According to C & W: 'As public relations professionals, it's our job to really understand the conversations happening among our clients' customers, patients, physicians, policy makers, and payors. Much of today's conversation is happening in social media channels, and this is true for healthcare.'<ref>Cohn & Wolfe. [http://www.cohnwolfe.com/en/practice/healthcare/overview Cohn & Wolfe Practices]. Accessed on 24 October 2009.</ref> The agency claims to be an expert in working in the complex environment where healthcare providers, patients, caregivers, advocacy groups and manufacturers engage in digital communications channels like social communities, blogs, and various audio/video sites. | ||
==Dabbling with fake blogging== | ==Dabbling with fake blogging== | ||
| Line 54: | Line 62: | ||
*[[Tom Petrosini]], CFO, Cohn & Wolfe Worldwide | *[[Tom Petrosini]], CFO, Cohn & Wolfe Worldwide | ||
*[[Jonathan Shore]], Managing Director, Cohn & Wolfe London | *[[Jonathan Shore]], Managing Director, Cohn & Wolfe London | ||
| + | |||
| + | Healthcare: [[Linda Dyson]] Healthcare Practice Leader | ||
==Contact details== | ==Contact details== | ||
| − | Cohn & Wolfe London | + | :Address: |
| − | 7-12 | + | :Cohn & Wolfe London/EMEA |
| − | Lynton House | + | :7-12 Tavistock Square |
| − | London, WC1H 9LT | + | :Lynton House |
| + | :London, WC1H 9LT | ||
| + | :United Kingdom | ||
| + | |||
| + | :Phone: | ||
| + | :+44 (0)207 331 5300 | ||
| + | :Fax: +44 (0)207 331 9083 | ||
| + | |||
| + | :Website: | ||
| + | :http://www.cohnwolfe.com/ | ||
292 [[Madison Avenue]] <br> | 292 [[Madison Avenue]] <br> | ||
New York, NY 10017<br> | New York, NY 10017<br> | ||
Phone: 212.798.9700<br> | Phone: 212.798.9700<br> | ||
| − | |||
| − | |||
==Resources== | ==Resources== | ||
| Line 75: | Line 92: | ||
[[Category: Public relations firms]][[Category:Lobbying firms]] | [[Category: Public relations firms]][[Category:Lobbying firms]] | ||
[[Category:Food lobbyists and PR consultants]][[Category:Pharma]] | [[Category:Food lobbyists and PR consultants]][[Category:Pharma]] | ||
| + | [[Category: Big Pharma]] | ||
Revision as of 13:59, 24 October 2009
|
This article is part of the Pharma_Portal project of Spinwatch. |
Cohn & Wolfe - a subsidiary of WPP - describes itself as a "strategic marketing public relations firm dedicated to creating, building and protecting the world's most prolific brands."[1] It has offices all over the world including UK, US, throughout Europe, Latin America, Middle East, and the Asia Pacific region.
The firm claims to be an agency for the 'new communications landscape'. It is a global public relations agency with 50 offices in major markets around the world. They 'offer a powerful combination of breakthrough, brand-building creativity and pioneering digital and social media strategies.' [2]
The firm's 10 industry practices are Consumer Branding, Corporate, Digital, Energy, Entertainment, Healthcare, Public Affairs, Sports Marketing, Sustainability and Technology.
It offers clients 'strategic partnerships' with other WPP companies, including Quinn Gillespie, a lobbying firm.
Cohn and Wolfe has also teamed up with lobbying firm Open Road in the UK. [3]
Contents
Healthcare
Cohne & Wolfe recognise that Healthcare PR is changing and encourage clients to search for new models in communicating effectively to healthcare professionals, consumers and payors. The agency in turn creates 'bold creative strategies' with a focus on providing consumers with more information to take more active roles in their healthcare. According to C & W: 'As public relations professionals, it's our job to really understand the conversations happening among our clients' customers, patients, physicians, policy makers, and payors. Much of today's conversation is happening in social media channels, and this is true for healthcare.'[4] The agency claims to be an expert in working in the complex environment where healthcare providers, patients, caregivers, advocacy groups and manufacturers engage in digital communications channels like social communities, blogs, and various audio/video sites.
Dabbling with fake blogging
Fake blogs - a form of viral marketing in which PR or advertising agencies attempt to generate interest in their client's product by creating a fictional character on the internet - are drawing criticism from real bloggers. Cohn & Wolfe apologized in 2005 after "using a fictional character to leave a series of thinly veiled advertisements on blogs and other websites. A number of websites were hit last week with messages from Barry Scott," a fictional spokesman for a British household cleaning product.
British blogger Tom Coates was especially outraged and called it "a new low for marketers" after he wrote an emotional account of his relationship with his father, and then received comment spam from "Barry Scott" disguised as condolences. Coates replied: "My view was that any right-thinking person would view trying to market your product on such a post as revolting, corrupt, cynical, disgusting, sick and dishonourable."[5][6][7]
Ghost-written journal articles
Cohn & Wolfe was at the centre of a scandal in which Eli Lilly (a Cohn & Wolfe client) officials ghost-wrote studies for medical journals. The articles plugged an Eli Lilly drug, the antipsychotic Zyprexa, and were published under the names of credentialed scientists.[8]
Zyprexa is controversial because it is administered by internal injection and is sometimes given forcibly to psychiatric patients. It is also controversial because of its severe listed side-effects, which can include diabetes and tardive dyskinesia (involuntary movements of the mouth, tongue, jaw, or eyelids). The latter side-effect is in some cases irreversible.[9]
In spite of these drawbacks, Lilly sought to make Zyprexa “the number one selling psychotropic in history,” Bloomberg.com reports. In order to make the drug attain its "sales goal", Eli Lilly hired ghost-writers to prepare the articles for publication in medical journals. Documents unsealed as a result of a lawsuit against Eli Lilly for overpricing its drugs reveal that Cohn & Wolfe played a PR role in this process.
Bloomberg.com reports:
- “The paper for the Progress in Neurology and Psychiatry supplement has been completed and sent to the journal for peer review,” Kerrie Mitchell, an employee of the public relations agency Cohn & Wolfe, wrote in a Feb. 23, 2001, e-mail to Michael Sale, a Lilly marketing official. The message was among the unsealed files.
- “We ‘ghost’ wrote this article and then worked with author Dr. Haddad to work up the final copy,” Mitchell said in the e- mail. Eric Litchfield, a spokesman for Cohn & Wolfe, didn’t immediately return a call seeking comment... Peter Haddad, a researcher at Greater Manchester West Mental Health NHS Foundation Trust in the U.K., was listed as the article’s lead author. [10]
Rebranding shyness as national disease problem
According to a story by Martha Rosenberg on AlterNet, Cohn & Wolfe is credited with rebranding shyness as a disease that requires medication with the drug Paxil:
- Slick PR firm Cohn and Wolfe is credited with vaulting "shyness" to a national psychiatric problem, the answer for which is Paxil, and creating faux grassroots patient groups like Freedom From Fear to push their clients' drugs.[11]
Paxil is an antidepressant drug of the SSRI (selective serotonin reuptake inhibitor) type, manufactured by GlaxoSmithKline. It became controversial after a Wyoming, USA lawsuit in 2001 brought against GlaxoSmithKline. The jury decided that Paxil was implicated in a tragic case where a 60-year-old man, Donald Schell, shot and killed his wife, daughter and granddaughter and then himself after taking Paxil for only two days. The jury, assisted by the expert testimony of Dr David Healy, a well known critic of SSRIs, concluded that Paxil "can cause some people to become homicidal and/or suicidal." GlaxoSmithKline was ordered to pay the plaintiffs, members of Mr Schell's family, $8 million.[12]
Clients
As of June 2009 O'Dwyer's Directory of PR Firms lists Cohn & Wolfe clients as including:[13] 3M | ADP | American Foundation for Suicide Prevention | Chevron Texaco | Coca-Cola | Colgate-Palmolive | Danone | Diageo | DuPont | Eli Lilly & Co. | Epson | Hewlett-Packard | Hilton Hotels | Illycafe | Intel | M&M/Mars | McDonald's | Merck | Novartis | PGA | Pfizer | Seagram's (Absolut) | Sears | Smuckers | Sony | Taco Bell
Personnel
Senior management team
- Doug Buemi, Vice Chairman, Cohn & Wolfe Worldwide
- Sarah Descher, account manager, Cohn & Wolfe London
- Christiane Dirkes, Managing Director, Cohn & Wolfe Frankfurt
- Victoria Dix, Managing Director, Cohn & Wolfe Geneva
- Patricia Godefroy, EVP, General Manager, Cohn & Wolfe Los Angeles
- Franco Guzzi, Managing Director, Cohn & Wolfe Milan
- Donna Imperato, President and CEO, Cohn & Wolfe Worldwide
- Jean-François LeBrun, EVP, General Manager, Cohn & Wolfe Montreal
- Annie Longsworth, Managing Director, Cohn & Wolfe San Francisco
- Michael O'Brien, President, General Manager, Cohn & Wolfe New York
- Carol J. Panasiuk, EVP, General Manager, Cohn & Wolfe Toronto
- Rose de la Pascua, Managing Director, Cohn & Wolfe Madrid
- Tom Petrosini, CFO, Cohn & Wolfe Worldwide
- Jonathan Shore, Managing Director, Cohn & Wolfe London
Healthcare: Linda Dyson Healthcare Practice Leader
Contact details
- Address:
- Cohn & Wolfe London/EMEA
- 7-12 Tavistock Square
- Lynton House
- London, WC1H 9LT
- United Kingdom
- Phone:
- +44 (0)207 331 5300
- Fax: +44 (0)207 331 9083
- Website:
- http://www.cohnwolfe.com/
292 Madison Avenue
New York, NY 10017
Phone: 212.798.9700
Resources
References
- ↑ Cohn & Wolfe website
- ↑ Cohn & Wolfe. Cohn & Wolfe About Us. Accessed on 24 October 2009.
- ↑ APPC register, 12 2006 - 03 2007
- ↑ Cohn & Wolfe. Cohn & Wolfe Practices. Accessed on 24 October 2009.
- ↑ Tom Coates, On Cillit Bang and a new low for marketers...", Plasticbag.org, September 30, 2005.
- ↑ An apology from the Cillit Bang team...", Plasticbag.org, October 4, 2005
- ↑ Bobbie Johnson, "Cleaner caught playing dirty on the net", The Guardian (UK), October 6, 2005
- ↑ Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk, "Eli Lilly "ghost-wrote" articles to market Zyprexa, files show", Bloomberg, 123 June 2009, accessed 23 June 2009
- ↑ Zyprexa, Zydis, MedicineNet.com, accessed 23 June 2009
- ↑ Elizabeth Lopatto, Jef Feeley and Margaret Cronin Fisk, "Eli Lilly "ghost-wrote" articles to market Zyprexa, files show", Bloomberg, 123 June 2009, accessed 23 June 2009
- ↑ Martha Rosenberg, Are You One of Big Pharma's Lab Animals?, AlterNet, 7 December 2007, accessed June 23 2009
- ↑ Evelyn Pringle, "Uphill Battle - Warning Pharma Customers about Dangers of SSRIs", lawyersandsettlements.com, 29 September 2006, accessed 23 June 2009
- ↑ Cohn & Wolfe, O'Dwyer's, accessed 17 June 2009
